iBio Announces Production of Biosimilar Rituximab with its iBioLaunch™ Technology Sacramento Bee Rituximab is a chimeric mouse-human monoclonal antibody that binds to the CD20 antigen presented on the B-cell surface. Scientists at iBio's research and development partner, the Fraunhofer USA Center for Molecular Biotechnology, have expressed the ... |
